Morgan Stanley’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $169M | Buy |
|
|||||
|
2025
Q1 | $211M | Sell |
|
|||||
|
2024
Q4 | $307M | Buy |
|
|||||
|
2024
Q3 | $97.8M | Buy |
|
|||||
|
2024
Q2 | $81.3M | Buy |
|
|||||
|
2024
Q1 | $96.3M | Sell |
|
|||||
|
2023
Q4 | $371M | Buy |
|
|||||
|
2023
Q3 | $61.2M | Buy |
|
|||||
|
2023
Q2 | $68.9M | Buy |
|
|||||
|
2023
Q1 | $49.7M | Buy |
|
|||||
|
2022
Q4 | $15.5M | Buy |
|
|||||
|
2022
Q3 | $15.3M | Sell |
|
|||||
|
2022
Q2 | $20.5M | Buy |
|
|||||
|
2022
Q1 | $12.9M | Buy |
|
|||||
|
2021
Q4 | $3.2M | Sell |
|
|||||
|
2021
Q3 | $5.84M | Sell |
|
|||||
|
2021
Q2 | $14.5M | Buy |
|
|||||
|
2021
Q1 | $6.52M | Buy |
|
|||||
|
2020
Q4 | $5.74M | Buy |
|
|||||
|
2020
Q3 | $1.2M | Sell |
|
|||||
|
2020
Q2 | $1.84M | Buy |
|
|||||
|
2020
Q1 | $1.33M | Sell |
|
|||||
|
2019
Q4 | $3.75M | Sell |
|
|||||
|
2019
Q3 | $9.93M | Buy |
|
|||||
|
2019
Q2 | $303K | Sell |
|
|||||
|
2019
Q1 | $24.3M | Buy |
|
|||||
|
2018
Q4 | $747K | Sell |
|
|||||
|
2018
Q3 | $1.07M | Sell |
|
|||||
|
2018
Q2 | $1.75M | Buy |
|
|||||
|
2018
Q1 | $453K | Buy |
|
|||||
|
2017
Q4 | $410K | Buy |
|